APMD today
$17.80+$1.52 (+9.34%)close Nov 17, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bullish
1 hourStrong Bullish
15 minStrong Bullish
5 minSymmetric Triangle
Daily trend turns up above $19.57
Key levels
Resistance$24.50
Resistance$19.57
Support$16.43
Support$13.88
Latest news & SEC filings
EarningsApnimed Posts Q3 2026 Results, Gives Business Update
EarningsApnimed posts quarterly loss of $1.05 per share, revenue $2.480M
SEC FilingApnimed, Inc. filed a report on a major company event (Form 8-K)
All APMD news →Nasdaq · Healthcare
Apnimed, Inc. (APMD)
What Is the Price Target for APMD?
SEPT Low Target
$41.00
SEPT Mid Target
$50.00
SEPT High Target
$60.00
Analyst Consensus
$50.00
Is APMD a Buy or Sell Right Now?
Thesis
Test your own strategy on APMD
Describe your strategy in plain words, then scan, alert, backtest and paper trade it on APMD with SEPT’s own market data.
Start Free Trial →Is APMD Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$50.00
0
Moat Score
NONE
0/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with APMD?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See Smart Money Data →APMD Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
N/A
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for APMD
PREVIEWRecent off-exchange (dark pool) prints for APMD: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:43:08 | $17.44 | 2,866 | $$50K | BUY |
| 15:56:50 | $16.79 | 1,061 | $$18K | SELL |
| 15:27:08 | $16.88 | 1,473 | $$25K | BUY |
| 15:21:10 | $16.84 | 2,000 | $$34K | BUY |
| 15:18:45 | $16.85 | 1,000 | $$17K | BUY |
5 dark pool trades shown · $$143K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Apnimed, Inc. (APMD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
Your strategy, tested before real money.
Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.
Try SEPT Free for 7 Days →APMD — frequently asked questions
What is APMD stock price today?
Apnimed, Inc. (APMD) is at $17.80, up 9.34% (+$1.52) at the Nov 17, 2026 close.
Why is APMD stock up today?
Nov 16, 2026: Apnimed (APMD) reported Q3 2026 results, posting a quarterly loss of $1.05 per share that was wider than the $0.59 loss analysts had projected, while revenue fell to $2.480 million from $8.802 million a year earlier. The company also filed a Form 8-K disclosing a major corporate event alongside its business update.
What is the APMD price target?
The average analyst price target for APMD is $50.00, ranging from $41 to $60, based on 3 analysts. Latest: LifeSci Capital initiates on Aug 25, 2026.
What do analysts rate APMD?
Analyst ratings for APMD: 4 Buy, 0 Hold, 0 Sell — consensus Strong Buy.
Did APMD beat earnings?
APMD last reported on Nov 16, 2026: EPS -$1.05 vs -$0.59 expected — a miss of 78.0%.
What are APMD support and resistance levels?
Support: $16.43, $13.88. Resistance: $19.57, $24.50, $30.22.
What are insiders doing with APMD?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on APMD?
Nov 16, 2026: Apnimed Posts Q3 2026 Results, Gives Business Update · Nov 16, 2026: Apnimed posts quarterly loss of $1.05 per share, revenue $2.480M · Nov 16, 2026: Apnimed, Inc. filed a report on a major company event (Form 8-K)